NuCana (NCNA) Stock Price, Quote, News & History | Benzinga

NuCana PLC (NCNA) Stock Price, Quote, News & History

NCNANASDAQ

Trade with Public

Trade with Public

$1.38

-0.09-6.12%

At close: Aug 31, 5:00 PM EST

$1.39

-0.0805-5.48%

Pre-Market: 4:41 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Stock Report

Key Statistics

Open

-

Close

$1.38

Volume / Avg.

755.00 / 64.84K

Day Range

- - -

52 Wk Range

1.21 - 7.22

Market Cap

$5.78M

P/E Ratio

0.02

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

3.23%

Days to Cover

3

Recent NuCana PLC News

AST SpaceMobile, SBC Medical Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session

U.S. stock futures fall around 250 points on Monday. ASTS shares drop 13.5% after satellite placed in lower-than-planned orbit. Other stocks decline in pre-market trading.

Avi Kapoor

Unusual Machines, NuCana, Navigator Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session

US stock futures lower, Dow falls 200 points. Unusual Machines Inc announces public offering, shares drop 7.5%. Other stocks decline in pre-market.

Avi Kapoor

Clearpoint Neuro, Valneva, Rocket Lab And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Dow futures up 200 points, ClearPoint Neuro (CLPT) stock falls after wider-than-expected quarterly loss. Other stocks moving lower in pre-market.

Avi Kapoor

Why Delcath Systems Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Penguin Solutions Posts Q4 Earnings, Joins Esperion Therapeutics, Joby Aviation And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.12M

Investing Cash Flow (TTM)

373.00K

Financing Cash Flow (TTM)

15.29M

Free Cash Flow (TTM)

-5.33M

Capital Expenditure (TTM)

-208.00K

Net Change in Cash (TTM)

10.55M

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

-$19.77M

PE Ratio (TTM)

0.02

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

0.21

Earnings Yield % (TTM)

4905.69%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$6.59

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$40.00K

Total Cash

$19.50M

Debt to Equity

0.03

Issuance of Debt (TTM)

-$40.00K

Repayment of Debt (TTM)

-$40.00K

Key Statistics

Open

-

Close

$1.38

Volume / Avg.

755.00 / 64.84K

Day Range

- - -

52 Wk Range

1.21 - 7.22

Market Cap

$5.78M

P/E Ratio

0.02

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

3.23%

Days to Cover

3

About

Sector

Health Care

Industry

Biotechnology

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mec...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy NuCana (NCNA) stock?

A

You can purchase shares of NuCana (NASDAQ:NCNA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are NuCana (NCNA) competitors?

A

Other companies in NuCana’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for NuCana (NCNA) stock?

A

NuCana has a consensus price target of $15.50.

Q

What is the current price for NuCana (NCNA)?

A

The stock price for NuCana (NASDAQ: NCNA) is $1.3895 last updated September 2, 2026 at 5:52 AM EDT.

Q

Does NuCana (NCNA) pay a dividend?

A

There are no upcoming dividends for NuCana.

Q

When is NuCana (NASDAQ:NCNA) reporting earnings?

A

NuCana does not have any upcoming earnings scheduled.

Q

Is NuCana (NCNA) going to split?

A

There is no upcoming split for NuCana.

Q

What sector and industry does NuCana (NCNA) operate in?

A

NuCana is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.